Andrew Sanchez
Nurse Practitioner · Miami, FLNPI 1790305746
Payments from drug & device makers
Across 108 payments — averaging $16.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$308
- Amgen$255
- AbbVie$211
- Astellas Pharma US Inc$130
- AstraZeneca$129
- Lilly USA, LLC$90
- plus $633 from 21 others
What the payments were for
- Food & beverage$1,755100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 25 | $308 |
| Amgen | 17 | $255 |
| AbbVie | 10 | $211 |
| Astellas Pharma US Inc | 9 | $130 |
| AstraZeneca | 7 | $129 |
| Lilly USA, LLC | 6 | $90 |
| Otsuka America Pharmaceutical, Inc. | 4 | $70 |
| Sanofi-aventis U.S. LLC | 3 | $68 |
| Novartis | 2 | $51 |
| Bayer | 3 | $50 |
| Boehringer Ingelheim | 2 | $40 |
| Boston Scientific | 1 | $36 |
| Pfizer | 2 | $35 |
| Esperion Therapeutics, Inc. | 2 | $34 |
| Dexcom, Inc. | 2 | $31 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $31 |
| Amarin Pharma, Inc. | 1 | $23 |
| Biohaven Pharmaceuticals, Inc. | 1 | $22 |
| Inogen, Inc. | 1 | $19 |
| Merck | 1 | $18 |
| Eisai Inc. | 1 | $17 |
| Medtronic | 1 | $16 |
| GSK | 1 | $16 |
| Roche Diabetes Care, Inc. | 1 | $16 |
| Nestle Healthcare Nutrition Inc. | 1 | $15 |
| Exact Sciences | 1 | $14 |
| Sunovion Pharmaceuticals Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DALVANCE$115
How this compares
$1,755 in reported general payments places this provider in the 80th percentile of 8,290 nurse practitioner providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 40 | $500 |
| CefuroximeCefuroxime Axetil | 25 | $300 |
| Metoprolol Succinate | 16 | $267 |
| Atorvastatin Calcium | 44 | $246 |
| Lisinopril | 15 | $205 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 18 | $154 |
| Amlodipine Besylate | 31 | $146 |
| Tamsulosin Hcl | 12 | $115 |
| Losartan Potassium | 11 | $102 |
| Doxycycline Hyclate | 11 | $66 |
| Prednisone | 20 | $22 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Miami
- Margarita FernandezMiami$311K
- Maya BloombergMiami$202K
- Haydee KapinMiami$97K
- Terri PollackMiami$59K
- Amber FederizoMiami$39K
- Patricia Novoa-VogtMiami$35K
- Moriane JosephMiami$23K
- Jolanta BaginskiClearwater$494K
- Adissa PerezWinter Park$370K
- April WessonTampa$342K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.